Financial Instruments Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis

The fair value hierarchy table for the reporting date noted is as follows:

	1		1		1		1
	Fair Value Measurement on a Recurring Basis at Reporting Date Using¹
	Level-1 Inputs		Level-2 Inputs		Level-3 Inputs		Total
September 30, 2025
2024 Convertible Notes	$	—	$	—	$	22,300	$	22,300
Totals	$	—	$	—	$	22,300	$	22,300

	Level-1 Inputs		Level-2 Inputs		Level-3 Inputs		Total
December 31, 2024
2024 Convertible Notes	$	—	$	—	$	18,600	$	18,600
Totals	$	—	$	—	$	18,600	$	18,600
Fair value of liability	$	—	$	—	$	18,600	$	18,600

¹	There were no transfers between the respective Levels during the nine months ended September 30, 2025.

Schedule of Fair Value Assumption Used

The estimated fair value of the 2024 Convertible Notes as of each September 30, 2025 and December 31, 2024 was computed using a Monte Carlo simulation of the present value of its cash flows using a synthetic credit rating analysis and a required rate-of-return, using the following assumptions:

Schedule of Fair Value Assumption Used

	2024 Convertible Notes: September 30, 2025			2024 Convertible Notes: December 31, 2024
Fair Value	$	22,300		$	18,600
Face value principal payable	$	21,975		$	21,975
Required rate of return		28.70	%		29.00	%
Conversion Price	$	1.00		$	1.00
Value of common stock	$	1.01		$	0.819
Expected term (years)		4.15			4.90
Volatility		40.00	%		40.00	%
Risk free rate		3.62	%		4.28	%
Dividend yield		—	%		—	%

Lucid Diagnostics Inc. 10-Q